Company Data
Belite Bio Inc
Ticker
BLTE
Current Price
$61.4 2.88%
Market Cap
$2.0B
Price Target
Refer to Report
Volume
37.7K
52wk Range
$43.7 - $86.53
Overview
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.